清华大学与拜耳医药自2009年以来一直保持战略合作伙伴关系。2022年4月，清华与拜耳继续签署了为期三年的第五期战略合作协议。拜耳积极支持清华大学研究人员进行创新探索，目前拜耳研究员奖、拜耳科研转化基金正在招募申请。
拜耳研究员
自2009年以来，拜耳每年为评选出的清华大学研究人员颁发拜耳研究员奖，以表彰他们在与拜耳契合的研究领域中的卓越科学成就。2022年，拜耳将支持三位拜耳研究员，每位获奖者将获得15万元奖金支持，并与拜耳科学家建立联系探讨可能的研究合作。
拜耳科研转化基金
为鼓励药物发现领域的研究转化，拜耳将为清华大学研究人员提供每年总额为120万元的科研转化基金，用于支持最多3个科研转化项目，每个项目可获得总计40万元的资金，项目期限最长为两年。该基金用于支持清华大学研究人员进行自由的创新探索，来自科研转化基金项目的成果全部由清华大学拥有。
注：
1）在同一年内，同一研究人员不得同时被评选为拜耳研究员和科研转化基金的获得者。
2）申请面向清华生命、医、药及相关学科的独立科研负责人开放。
3）基金申请截止日期：2022年8月20日。
有关申请及评选过程的更多信息，请点击以下附件。请将申请发送至清华或拜耳的项目合作联系人:
刘迎辉（清华大学生命科学与医学研究院）
电话: +86 10 62795305
手机: +86 13164201518
E-mail: yhliu624@mail.tsinghua.edu.cn
未敏（拜耳处方药中国合作创新中心）
电话: +86 21 61593553
手机: +86 15921237622
E-mail: min.wei@bayer.com
清华大学生命科学与医学研究院
2022 Bayer Investigator Award and Microfunding Call for Proposals
Tsinghua has been in strategic partnership with Bayer since 2009. In Apr 2022, Tsinghua and Bayer renewed another three years of strategic collaboration, which is the 5th phase strategic partnership. Bayer has been actively supporting professors in Tsinghua for innovation exploration. Currently, two fundings from Bayer namely the Bayer Investigator Award and Microfunding are open for application.
Bayer Investigator Award
Bayer Investigator Award is presented annually since 2009 to Tsinghua Investigators for their scientific excellence in the research field relevant to Bayer Pharma R&D. In 2022, Bayer will support up to three investigators in Tsinghua, each selected Bayer Investigator will receive 150 kCNY award, and will get connected to Bayer scientists for potential research collaboration discussion.
Bayer Microfunding
To encourage research translation in drug discovery, Bayer will support Tsinghua in three Microfunding projects by an aggregate amount of up to 1.2 million CNY per year. Each Microfunding project can be funded with up to a total of 400 kCNY for a maximum duration of two years. The funding is to support Tsinghua Investigators to freely explore innovation translation, therefore, any project results deriving from a Microfunding project will solely be owned by Tsinghua.
Please note that ,
1）The same person shall not be selected as Bayer Investigator and recipient of Microfunding simultaneously in the same calendar year.
2）The applications open to the Principle Investigators（PIs）in the area of life sciences, medicine or pharmaceuticals
3) The application deadline is August 20th, 2022.
More information regarding the application and selection process can be found in the attachment.
Please send your application to Tsinghua or Bayer alliance managers:
Yinghui Liu （Institute of Biomedicine，THU）
Tel: +86 10 62795305 Mobile: +86 13164201518 E-mail: yhliu624@mail.tsinghua.edu.cn
Min Wei（Collaborate to Cure Hub China Bayer Pharmaceuticals）
Tel: +86 21 61593553 Mobile: +86 15921237622 E-mail: min.wei@bayer.com
附件文件
